Clik here to view.
Covidien’s ev3 seeks new trial in $175M loss to Appriva
Covidien (NYSE:COV) subsidiary ev3 wants the Delaware Supreme Court to grant a new trial in a lawsuit over $175 million ev3 allegedly owes its own Appriva Medical acquisition. Last summer a jury in...
View ArticleClik here to view.
Medtech legal news for the week of Mar. 17, 2014
Appeals court applies Supreme Court ruling to Medtronic lawsuit against Boston Scientific March 12, 2014 by Brad Perriello A federal appeals court today reconsidered a lawsuit between Medtronic and...
View ArticleClik here to view.
Covidien’s Ev3 logs a pair of legal wins over Appriva, whistleblower
Covidien (NYSE:COV) subsidiary Ev3 logged a pair of legal wins in recent weeks when the Delaware Supreme Court overturned a $250 million loss to Ev3 acquisition Appriva Medical and a federal judge in...
View ArticleClik here to view.
Medtronic shareholder sues over company’s plan to cover nearly $58M in taxes...
Shareholder sues Medtronic over plan to cover execs' $58m tax tab October 7, 2014 by Brad Perriello A Medtronic shareholder sued the company last week over its plan to cover nearly $58 million in...
View ArticleClik here to view.
Medtronic’s new Ev3 unit pays $1.3m in whistleblower suit
The Ev3 subsidiary Medtronic (NYSE:MDT) acquired along with Covidien yesterday delivered good news and bad: FDA clearance for a new aneurysm treatment and a $1.25 million hit in a whistleblower...
View ArticleClik here to view.
MDT’s Ev3 pays $1.3m in whistleblower suit | The week in medtech M&A
Medtronic's new Ev3 unit pays $1.3m in whistleblower suit February 6, 2015 by Brad Perriello The Ev3 subsidiary Medtronic acquired along with Covidien yesterday delivered good news and bad: FDA...
View ArticleClik here to view.
MDT’s Ev3 pays $1.3m in whistleblower suit | Medtech legal news for the week...
Medtronic's new Ev3 unit pays $1.3m in whistleblower suit February 6, 2015 by Brad Perriello The Ev3 subsidiary Medtronic acquired along with Covidien yesterday delivered good news and bad: FDA...
View ArticleClik here to view.
PAD: Medtronic wins expanded FDA nod for Protégé GPS stent
Medtronic (NYSE:MDT) today said it won expanded approval from the FDA for the Protégé GPS peripheral stent it acquired along with Covidien earlier this year. The Protégé GPS self-expanding stent is...
View ArticleClik here to view.
BSX wins CE Mark, FDA nod for new S-ICD | Regulatory news for the week of...
Boston Scientific wins CE Mark, FDA nod for smaller 'leadless' ICD March 17, 2015 by Brad Perriello Boston Scientific today said it won both CE Mark approval in Europe and a nod at home from the FDA...
View ArticleClik here to view.
Sterilis taps ex-Nanosphere CEO McGarrity as chief exec | Personnel Moves –...
Medical sterilization company Sterilis said yesterday it tapped former Nanosphere (NSDQ:NSPH) chief exec Michael McGarrity as its new CEO. McGarrity held the CEO position at Nanosphere from February...
View ArticleClik here to view.
JenaValve names Kilcoyne as CEO | Personnel Moves – January 15, 2019
JenaValve Technology said today that it named former ReVision Optics prez & CEO John Kilcoyne as its new chief executive officer, effective immediately, replacing Dr. Victoria Carr-Brendell, who...
View ArticleClik here to view.
Medtronic asks judge to accept its negotiated $17.9m sentence in ev3 case
Medtronic (NYSE:MDT) wants the judge in its off-label marketing case against its neurovascular subsidiary ev3 to accept the sentence that the company and U.S. Justice Department have agreed upon....
View Article